tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market

Resmed (RMD) Income Statement

Compare
1,146 Followers

Resmed Income Statement

Last quarter (Q1 2026), Resmed's total revenue was $1.34B, an increase of 9.07% from the same quarter last year. In Q1, Resmed's net income was $348.54M. See Resmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.15B$ 4.69B$ 4.22B$ 3.58B$ 3.20B
Gross Profit
$ 3.05B$ 2.66B$ 2.36B$ 2.02B$ 1.84B
Operating Expenses
$ 1.37B$ 1.34B$ 1.22B$ 1.02B$ 935.42M
Depreciation and Amortization
$ 235.81M$ 216.21M$ 196.52M$ 193.84M$ 191.52M
EBITDA
$ 1.91B$ 1.53B$ 1.36B$ 1.18B$ 1.10B
Operating Income
$ 1.69B$ 1.32B$ 1.13B$ 1.00B$ 903.68M
Other Income/Expenses
$ -7.80M$ -55.09M$ -30.21M$ -39.80M$ -20.02M
Pretax Income
$ 1.68B$ 1.26B$ 1.10B$ 960.48M$ 883.66M
Net Income
$ 1.40B$ 1.02B$ 897.56M$ 779.44M$ 474.50M
Per Share Metrics
Basic EPS
$ 9.55$ 6.94$ 6.12$ 5.34$ 3.27
Diluted EPS
$ 9.51$ 6.92$ 6.09$ 5.30$ 3.24
Weighted Average Shares Outstanding
146.72M 147.02M 146.76M 146.07M 145.31M
Weighted Average Shares Outstanding (Diluted)
147.34M 147.55M 147.46M 147.04M 146.45M
Currency in USD

Resmed Earnings and Revenue History